Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Insmed (INSM)
NASDAQ:INSM
Holding INSM?
Track your performance easily
See the Price Targets and Ratings of:
INSM Analyst Ratings
Strong Buy
11 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
INSM Stock 12 Month Forecast
Average Price Target
$89.50
▲(22.35% Upside)
| Highest Price Target$105.00 | Average Price Target$89.50 | Lowest Price Target$75.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
Reiterated
11/22/24
Bank of America Securities
Reiterated
11/20/24
Leerink Partners
Reiterated
11/19/24
Mizuho Securities
Reiterated
11/08/24
Truist Financial
Reiterated
11/05/24
Morgan Stanley
Reiterated
11/01/24
TD Cowen
Assigned
11/01/24
Barclays
Reiterated
11/01/24
H.C. Wainwright
Reiterated
11/01/24
Evercore ISI
Assigned
11/01/24
Stifel Nicolaus
―
Buy
―
Reiterated
09/10/24
Insmed Maintains Competitive Edge Amid Lackluster Trial Results for Rival Drug BI 1291583
UBS
$78→$84
Buy
14.83%
Upside
Reiterated
08/09/24
Insmed (INSM) PT Raised to $84 at UBSUBS analyst Trung Huynh raised the price target on Insmed (NASDAQ: INSM) to $84.00 (from $78.00) while maintaining a Buy rating.
Wells Fargo
$77→$85
Buy
16.20%
Upside
Assigned
08/08/24
Insmed's Promising Outlook: Buy Rating Backed by Arikayce Performance and Brenso Launch Potential
Guggenheim
$70→$95
Buy
29.87%
Upside
Reiterated
07/09/24
Insmeds (NASDAQ:INSM) Potential Groundbreaking Drug - TipRanks.comGuggenheim analyst Vamil Divan recently raised the price target on the shares to $95 from $70 while maintaining a Buy rating, noting the encouraging feedback from bronchiectasis experts on the strength of the data and how broadly they expect to use Brensocatib in their patients, marking the firm as a Best Idea within the coverage universe.
Best Analysts Covering Insmed
Which Analyst Should I Follow If I Want to Buy INSM and Sell After:
1 Month
xxx
Success Rate
9/14 ratings generated profit
Average Return
+12.06%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.29% of your transactions generating a profit, with an average return of +12.06% per trade.
3 Months
xxx
Success Rate
12/14 ratings generated profit
Average Return
+41.66%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 85.71% of your transactions generating a profit, with an average return of +41.66% per trade.
1 Year
Success Rate
14/14 ratings generated profit
Average Return
+110.71%
reiterated a buy rating 3 days ago
Copying Jason Zemansky's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +110.71% per trade.
2 Years
xxx
Success Rate
14/14 ratings generated profit
Average Return
+162.04%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +162.04% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
INSM Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
11
0
0
0
2
Buy
51
45
30
26
22
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
62
45
30
26
24
Each month's total comprises the sum of three months' worth of ratings.
INSM Financial Forecast
INSM Stock Forecast FAQ
What is INSM’s average 12-month price target, according to analysts?
Based on analyst ratings, Insmed’s 12-month average price target is $89.50.
What is INSM’s upside potential, based on the analysts’ average price target?
Insmed has 22.35% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is INSM a Buy, Sell or Hold?
Insmed has a consensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
What is Insmed’s price target?
The average price target for Insmed is $89.50. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $105.00 ,the lowest forecast is $75.00. The average price target represents 22.35% Increase from the current price of $73.15.
The highest analyst price target is $105.00 ,the lowest forecast is $75.00. The average price target represents 22.35% Increase from the current price of $73.15.
What do analysts say about Insmed?
Insmed’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of INSM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.